Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,284,725
-
Total 13F shares
-
40,453,267
-
Share change
-
-10,625,662
-
Total reported value
-
$44,092,350
-
Put/Call ratio
-
7.7%
-
Price per share
-
$1.09
-
Number of holders
-
63
-
Value change
-
-$10,908,224
-
Number of buys
-
24
-
Number of sells
-
31
Institutional Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q1 2025
As of 31 Mar 2025,
IMMUNIC, INC. - Common Stock (IMUX) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,453,267 shares.
The largest 10 holders included
BVF INC/IL, Soleus Capital Management, L.P., Avidity Partners Management LP, VANGUARD GROUP INC, Focus Partners Wealth, Omega Fund Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Aberdeen Group plc, GEODE CAPITAL MANAGEMENT, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
63
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.